Ten-year prediction model for post-bronchodilator airflow obstruction and early detection of COPD: development and validation in two middle-aged population-based cohorts

Author:

Perret Jennifer LORCID,Vicendese Don,Simons Koen,Jarvis Debbie L,Lowe Adrian J,Lodge Caroline J,Bui Dinh S,Tan Daniel,Burgess John A,Erbas Bircan,Bickerstaffe Adrian,Hancock Kerry,Thompson Bruce R,Hamilton Garun S,Adams Robert,Benke Geza P,Thomas Paul S,Frith PeterORCID,McDonald Christine F,Blakely Tony,Abramson Michael JORCID,Walters E Haydn,Minelli Cosetta,Dharmage Shyamali C

Abstract

BackgroundClassifying individuals at high chronic obstructive pulmonary disease (COPD)-risk creates opportunities for early COPD detection and active intervention.ObjectiveTo develop and validate a statistical model to predict 10-year probabilities of COPD defined by post-bronchodilator airflow obstruction (post-BD-AO; forced expiratory volume in 1 s/forced vital capacity<5th percentile).SettingGeneral Caucasian populations from Australia and Europe, 10 and 27 centres, respectively.ParticipantsFor the development cohort, questionnaire data on respiratory symptoms, smoking, asthma, occupation and participant sex were from the Tasmanian Longitudinal Health Study (TAHS) participants at age 41–45 years (n=5729) who did not have self-reported COPD/emphysema at baseline but had post-BD spirometry and smoking status at age 51–55 years (n=2407). The validation cohort comprised participants from the European Community Respiratory Health Survey (ECRHS) II and III (n=5970), restricted to those of age 40–49 and 50–59 with complete questionnaire and spirometry/smoking data, respectively (n=1407).Statistical methodRisk-prediction models were developed using randomForest then externally validated.ResultsArea under the receiver operating characteristic curve (AUCROC) of the final model was 80.8% (95% CI 80.0% to 81.6%), sensitivity 80.3% (77.7% to 82.9%), specificity 69.1% (68.7% to 69.5%), positive predictive value (PPV) 11.1% (10.3% to 11.9%) and negative predictive value (NPV) 98.7% (98.5% to 98.9%). The external validation was fair (AUCROC 75.6%), with the PPV increasing to 17.9% and NPV still 97.5% for adults aged 40–49 years with ≥1 respiratory symptom. To illustrate the model output using hypothetical case scenarios, a 43-year-old female unskilled worker who smoked 20 cigarettes/day for 30 years had a 27% predicted probability for post-BD-AO at age 53 if she continued to smoke. The predicted risk was 42% if she had coexistent active asthma, but only 4.5% if she had quit after age 43.ConclusionThis novel and validated risk-prediction model could identify adults aged in their 40s at high 10-year COPD-risk in the general population with potential to facilitate active monitoring/intervention in predicted ‘COPD cases’ at a much earlier age.

Funder

GlaxoSmithKline Australia

Asthma Australia

University of Melbourne

National Health and Medical Research Council

Royal Hobart Hospital Research Foundation

Medical Research Council

European Commission

Clifford Craig Foundation

Publisher

BMJ

Subject

Pulmonary and Respiratory Medicine

Reference42 articles.

1. Australian Institute of Health and Welfare . Chronic obstructive pulmonary disease (COPD). Cat. No. ACM 35. Canberra: AIHW, 2019. https://www/aihw.gov.au/reports/chronic-respiratory-conditions/copd

2. Falster M , Jorm L . A guide to the potentially preventable hospitalisations indicator in Australia. Sydney: Centre for Big Data Research in Health, University of New South Wales in consultation with Australian Commission on Safety and Quality in Health Care and Australian Institute of Health and Welfare, 2017.

3. Prediction of Coronary Heart Disease Using Risk Factor Categories

4. AUSDRISK: an Australian type 2 diabetes risk assessment tool based on demographic, lifestyle and simple anthropometric measures;Chen;Med J Aust,2010

5. Wilson JMG , Jungner G . Principles and practice of screening for disease. Geneva: World Health Organization, 1968.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3